Model
Edge
Oyster Point Pharma Inc.
0001720725
Filing type
8-K/A
Filing date
Jan 12, 2023
Updated
Jan 13, 2023 ยท 10:06 AM
Copy reference
Filing
8-K/A
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws